NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Sohrab Shah

Genomic Disruption in High-Grade Serous Ovarian Carcinomas: Steady State or Continuous Drift?

Ovary

Nikhil C Munshi

Role of Combination Therapy with Novel Targeted Agents

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Simon A Gayther

The Contribution of Rare Alleles to Ovarian Cancer in the Population

Ovary

Pathology

Becca Asquith

KIR in adaptive immunity: in vivo relevance for human disease

Leukaemia Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Lisa Rimsza

Molecular Diagnosis and Prognosis in Aggressive Lymphoma

Non-Hodgkin lymphoma

Pathology Hematology and hematologic malignancies

Ajit P Varki

Oligosaccharies of Normal and Malignant Cells

Colorectum Breast

Xiaodong Zhang

Structural and mechanistic studies of the breast cancer tumour suppressor BRCA2 in DNA double strand break repair

Breast

Pathology

Susan L Slager

Genetic Epidemiology Of Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies Pathology

James Thrasher

Building Evidence for Effective and Sustainable Cigarette Warning Label Policy

Trachea, bronchus and lung Bladder